281 related articles for article (PubMed ID: 15379652)
1. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.
Sakaeda T; Nakamura T; Okumura K
Curr Top Med Chem; 2004; 4(13):1385-98. PubMed ID: 15379652
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.
Sakaeda T; Nakamura T; Okumura K
Pharmacogenomics; 2003 Jul; 4(4):397-410. PubMed ID: 12831320
[TBL] [Abstract][Full Text] [Related]
3. MDR1 genotype-related pharmacokinetics and pharmacodynamics.
Sakaeda T; Nakamura T; Okumura K
Biol Pharm Bull; 2002 Nov; 25(11):1391-400. PubMed ID: 12419946
[TBL] [Abstract][Full Text] [Related]
4. MDR1 genotype-related pharmacokinetics: fact or fiction?
Sakaeda T
Drug Metab Pharmacokinet; 2005 Dec; 20(6):391-414. PubMed ID: 16415525
[TBL] [Abstract][Full Text] [Related]
5. [MDR1 genotypes related to pharmacokinetics and MDR1 expression].
Nakamura T
Yakugaku Zasshi; 2003 Sep; 123(9):773-9. PubMed ID: 14513768
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.
Issac MS; El-Nahid MS; Wissa MY
Mol Diagn Ther; 2014 Feb; 18(1):73-83. PubMed ID: 24092646
[TBL] [Abstract][Full Text] [Related]
7. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
8. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
Jamroziak K; Balcerczak E; Smolewski P; Robey RW; Cebula B; Panczyk M; Kowalczyk M; Szmigielska-Kapłon A; Mirowski M; Bates SE; Robak T
Pharmacol Rep; 2006; 58(5):720-8. PubMed ID: 17085864
[TBL] [Abstract][Full Text] [Related]
9. Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities.
Morita N; Yasumori T; Nakayama K
Biochem Pharmacol; 2003 Jun; 65(11):1843-52. PubMed ID: 12781336
[TBL] [Abstract][Full Text] [Related]
10. Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and development.
Chen C; Liu X; Smith BJ
Curr Drug Metab; 2003 Aug; 4(4):272-91. PubMed ID: 12871045
[TBL] [Abstract][Full Text] [Related]
11. Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?
Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Gupta YK
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28367681
[TBL] [Abstract][Full Text] [Related]
12. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
14. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms.
Meissner K; Jedlitschky G; Meyer zu Schwabedissen H; Dazert P; Eckel L; Vogelgesang S; Warzok RW; Böhm M; Lehmann C; Wendt M; Cascorbi I; Kroemer HK
Pharmacogenetics; 2004 Jun; 14(6):381-5. PubMed ID: 15247630
[TBL] [Abstract][Full Text] [Related]
15. The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I; Takane H; Otsubo K
Clin Pharmacokinet; 2004; 43(9):553-76. PubMed ID: 15217301
[TBL] [Abstract][Full Text] [Related]
16. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.
Ameyaw MM; Regateiro F; Li T; Liu X; Tariq M; Mobarek A; Thornton N; Folayan GO; Githang'a J; Indalo A; Ofori-Adjei D; Price-Evans DA; McLeod HL
Pharmacogenetics; 2001 Apr; 11(3):217-21. PubMed ID: 11337937
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
Ishikawa T; Onishi Y; Hirano H; Oosumi K; Nagakura M; Tarui S
Biol Pharm Bull; 2004 Jul; 27(7):939-48. PubMed ID: 15256718
[TBL] [Abstract][Full Text] [Related]
18. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
Cascorbi I; Gerloff T; Johne A; Meisel C; Hoffmeyer S; Schwab M; Schaeffeler E; Eichelbaum M; Brinkmann U; Roots I
Clin Pharmacol Ther; 2001 Mar; 69(3):169-74. PubMed ID: 11240981
[TBL] [Abstract][Full Text] [Related]
19. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
[TBL] [Abstract][Full Text] [Related]
20. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.
Woodahl EL; Ho RJ
Curr Drug Metab; 2004 Feb; 5(1):11-9. PubMed ID: 14965248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
